Advertisement

Reactions Weekly

, Volume 1761, Issue 1, pp 2–2 | Cite as

Febuxostat: higher risk of CV-related death, all-cause mortality

News item

Reference

  1. Gillian A. Febuxostat: increased risk of cardiovascular death and all-cause mortality in patients treated with febuxostat in the CARES study. Internet Document : [3 pages], 27 Jun 2019. Available from: URL: https://www.hpra.ie/docs/default-source/default-document-library/important-safety-information---febuxostat.pdf?sfvrsn=0

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations